Concierge imaging · London
Breast MRI screening London.
Contrast-enhanced dynamic MRI for high-risk screening, dense breasts, silicone implant assessment, and post-treatment surveillance. Reported by a specialist breast radiologist, often independently double-read.
In short
Breast MRI sensitivity 90 to 95 percent in dense parenchyma, versus 60 to 70 percent for mammography alone.
Standalone MRI £850 to £1,400. Combined MRI, mammogram, ultrasound and consultation £1,600 to £2,400.
What breast MRI is
Contrast-enhanced dynamic imaging of both breasts, using gadolinium.
A dedicated breast MRI uses a purpose-built coil, thin high-resolution slices, and a bolus of intravenous gadolinium to map the enhancement pattern of every millimetre of breast tissue. Malignant lesions show early, avid enhancement with rapid washout; benign lesions enhance slowly or persistently. This dynamic behaviour, combined with morphology and diffusion, gives breast MRI a sensitivity of 90 to 95 percent for invasive cancer.
It is the most sensitive imaging modality available for breast cancer, and it does not depend on parenchymal density in the way mammography does. That combination makes it the reference test for high-risk annual screening, an adjunct in dense breasts, the arbiter for silicone implant integrity, and the tool of choice for staging a confirmed cancer or monitoring neoadjuvant response.
Indications
NICE and BSBR high-risk criteria, and where MRI earns its place beyond them.
NICE CG164 and BSBR high-risk protocols recommend annual MRI paired with mammography for women whose lifetime breast cancer risk exceeds 30 percent. Beyond that core group, MRI is used as an adjunct in dense breasts, for problem-solving equivocal findings, and for structural questions such as implant integrity.
-
BRCA1 and BRCA2 carriers
Annual MRI plus mammogram from age 30, per NICE CG164 and BSBR high-risk protocols.
-
Li-Fraumeni (TP53)
Annual MRI from age 20; mammography usually avoided under 30 owing to radiosensitivity.
-
Chest radiotherapy age 10 to 30
Prior mantle or chest-field radiotherapy, typically for Hodgkin lymphoma, meets high-risk criteria.
-
Strong family history
First-degree relative with premenopausal breast cancer, or lifetime risk above 30 percent on family-history modelling.
-
Dense breasts (BI-RADS C to D)
Adjunct to mammography where sensitivity drops below 70 percent on dense parenchyma.
-
Silicone implant assessment
Silicone-specific sequences for suspected intracapsular or extracapsular rupture, gel bleed, or BIA-ALCL.
-
Occult primary
Axillary nodal metastasis with mammographically and sonographically occult breast primary.
-
Nipple discharge
Investigation of pathological single-duct discharge where galactography and ultrasound are inconclusive.
-
Neoadjuvant response
Serial MRI to monitor response of a confirmed breast cancer to neoadjuvant chemotherapy.
-
Local recurrence
Detection of recurrence in the treated breast where mammography is limited by post-surgical change.
-
Problem-solving
Equivocal mammogram or ultrasound findings where MRI resolves the question before biopsy.
The procedure
Around 30 to 45 minutes, prone, with a cannula.
You lie face-down on a padded table with each breast suspended in a dedicated coil. The radiographer acquires localiser, T2 and diffusion-weighted sequences before giving intravenous gadolinium halfway through. Dynamic post-contrast series follow at approximately 60, 120, 180 and 240 seconds, capturing enhancement kinetics for every lesion.
The scanner is loud but the scan is painless. Breathing is normal throughout, and there is no compression as in mammography.
Timing and preparation
Day 7 to 14 of the cycle, if you have one.
- Premenopausal: schedule between day 7 and day 14 of the cycle to reduce background parenchymal enhancement.
- Postmenopausal or on continuous HRT: any time. Sequential HRT is ideally paused for four weeks.
- Arrive 30 minutes early for cannula insertion and safety check.
- Serum creatinine within the last three months, for gadolinium clearance.
- Hold breastfeeding for 24 hours after contrast; a pregnancy screen is performed on arrival.
Reporting
BI-RADS 1 to 6, specialist breast radiologist, often double-read.
A specialist breast radiologist reports every study using the BI-RADS lexicon, scoring 1 (normal) through 6 (biopsy-proven malignancy). Independent double-reading is standard in high-risk programmes. Recall for further imaging runs at 10 to 15 percent in the first round, mostly falling to targeted ultrasound. Ultrasound-guided or MR-guided biopsy is arranged for BI-RADS 4 or 5.
Silicone implant assessment
Silicone-specific sequences, no contrast required.
Water-suppressed T2 sequences differentiate silicone from surrounding tissue. MRI identifies intracapsular rupture (the linguine sign, keyhole sign, or subcapsular droplets), extracapsular rupture with free silicone in tissue, and gel bleed through an intact shell. It also detects the peri-implant fluid collection associated with breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Cost and where
£850 to £1,400 standalone; £1,600 to £2,400 as a full workup.
Standalone contrast-enhanced breast MRI runs £850 to £1,400 in central London, all-inclusive of scanner time, gadolinium, and a consultant breast radiologist report. A combined workup with mammogram, ultrasound and specialist consultation runs £1,600 to £2,400.
Where we route patients
- The London Breast Institute
- HCA The Portland Breast Unit
- HCA The Wellington Breast
- Cromwell BUPA Breast
- Chelsea and Westminster Private Breast
- London Medical
- One Welbeck Women's Health
- Royal Marsden Private Breast
NHS availability: eligible high-risk women access annual MRI from age 30 to 50 through the Family History Clinic pathway. Ask your GP for a referral if you meet the criteria; we are happy to help interpret eligibility.
Frequently asked
Six questions we get every week.
-
I am a BRCA carrier. What screening should I have?
Under NICE CG164 and BSBR guidance, BRCA1 and BRCA2 carriers should have annual breast MRI from age 30 to 50, paired with annual mammography (mammography usually deferred to age 40 for BRCA1 to limit radiation exposure). We arrange the pathway with a specialist breast radiologist and forward the report to your genetics team or GP.
-
Will private medical insurance cover breast MRI screening?
Most UK insurers cover MRI where there is a clinical indication such as a confirmed BRCA mutation, strong family history, dense breasts with an abnormal finding, or investigation of a mass. Pure screening on personal request is often self-pay. We handle pre-authorisation with Bupa, AXA, Vitality, Aviva, WPA and Cigna before booking.
-
Can breast MRI detect silicone implant rupture?
Yes. Silicone-specific sequences (water-suppressed T2, no contrast required) are the reference standard for implant integrity. MRI identifies intracapsular rupture through the linguine and keyhole signs, extracapsular free silicone, and gel bleed. It also picks up peri-implant fluid collections associated with BIA-ALCL.
-
How often does breast MRI cause a false positive?
Recall for further imaging runs at roughly 10 to 15 percent in the first screening round, falling to 5 to 8 percent thereafter as prior comparators become available. Most recalls resolve on targeted ultrasound; ultrasound-guided or MR-guided biopsy is only needed for BI-RADS 4 or 5 findings.
-
When in my cycle should I book the scan?
Premenopausal women should be scanned on day 7 to 14 of the cycle. This minimises background parenchymal enhancement and improves sensitivity. Postmenopausal women, and those on continuous HRT, can be scanned at any time; we usually advise pausing sequential HRT for four weeks if practical.
-
Is the gadolinium contrast safe?
Macrocyclic gadolinium agents used in the UK have an excellent safety record. We require a serum creatinine within three months, screen for previous contrast reaction, and defer scanning in pregnancy. Breastfeeding can continue after 24 hours. Nephrogenic systemic fibrosis is not a concern with modern agents in patients with normal kidney function.
Related
Looking for a different test or the wider pathway?
Book your breast MRI
A specialist breast radiologist, a proper protocol, a report you can act on.
Tell us your risk profile and the question you need answered. We come back with a firm quote, an appointment inside the week, and the right radiologist for your case.